Bascom Palmer Eye Institute, School of Medicine and Miami Children's Hospital, University of Miami Miller, Miami, Florida 33136, USA.
J Neuroophthalmol. 2010 Dec;30(4):305-10. doi: 10.1097/WNO.0b013e3181e08ecb.
A 55-year-old man with pulmonary Mycobacterium avium intracellulare infection developed decreased vision to 3/200 in the right eye, and 20/200 in the left eye, 11 months after starting ethambutol, rifampin, and isoniazid. A diagnosis of presumed ethambutol optic neuropathy was made, and the medications were discontinued. Visual acuity gradually improved to 20/30 and 20/70 over a period of 34 months. Despite improved central vision and visual field, the patient developed progressive bilateral optic disc cupping, disc pallor, and diffuse nerve fiber layer loss on optical coherence tomography. The observed optic nerve head structural changes in this patient did not correlate with the markedly improved visual function. Visual improvement may occur in ethambutol optic neuropathy despite progressive structural changes.
一名 55 岁男性,在开始使用乙胺丁醇、利福平、异烟肼 11 个月后,出现右侧视力下降至 3/200,左侧视力下降至 20/200,诊断为疑似乙胺丁醇视神经病变,停用了这些药物。视力逐渐恢复,在 34 个月期间分别恢复至 20/30 和 20/70。尽管中心视力和视野有所改善,但患者出现进行性双侧视盘杯状、视盘苍白和光学相干断层扫描显示弥漫性神经纤维层丢失。该患者观察到的视神经头结构变化与明显改善的视觉功能不相关。尽管存在进行性结构改变,但乙胺丁醇视神经病变仍可能出现视力改善。